AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24791346 — intervention group
Group type: COMPARATOR
Intervention: Two doses of ivermectin
Number of subjects: 60
Study 22129125 — intervention group
Group type: EXPERIMENTAL
Intervention: 28-day feeding group
Number of subjects: 31
Study 22129125 — intervention group
Group type: EXPERIMENTAL
Intervention: 56-day feeding group
Number of subjects: 31
Study 22129125 — intervention group
Group type: EXPERIMENTAL
Intervention: Both feeding groups
Number of subjects: 31
Study 22129125 — intervention group
Group type: COMPARATOR
Intervention: Control group (immediate slaughter)
Number of subjects: 31
Study 19336428 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral recession (BR)
Number of subjects: 124
Study 19336428 — intervention group
Group type: COMPARATOR
Intervention: Unilateral recession-resection (RR)
Number of subjects: 124
Study 19336428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study 16449486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 25 mg/day
Number of subjects: 207
Study 16449486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 50 mg/day
Number of subjects: 207
Study 16449486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 100 mg/day
Number of subjects: 207
Study 16449486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 15290730 — intervention group
Group type: EXPERIMENTAL
Intervention: LEF (10 mg/day, no loading dose) + MTX
Number of subjects: 192
Study 15290730 — intervention group
Group type: COMPARATOR
Intervention: PLA + MTX switched to LEF (10 mg/day, no loading dose)
Number of subjects: 192
Study 15290730 — intervention group
Group type: EXPERIMENTAL
Intervention: LEF (initially randomized)
Number of subjects: 192
Study 15290730 — intervention group
Group type: EXPERIMENTAL
Intervention: LEF (no loading dose)
Number of subjects: 192
Study 11273907 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-enhanced cardioplegia (Humulin R 10 IU/L, Insulin group, n = 243)
Number of subjects: 501
Study 11273907 — intervention group
Group type: COMPARATOR
Intervention: Standard blood cardioplegia (Control group, n = 258)
Number of subjects: 501
Study 11273907 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-enhanced cardioplegia
Number of subjects: 501
Study 11273907 — intervention group
Group type: COMPARATOR
Intervention: Standard blood cardioplegia
Number of subjects: 501
Study 11273907 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population (n = 501)
Number of subjects: 501
Study 9032510 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of breathing recording
Number of subjects: 74
Study 9032510 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing through mouthpiece
Number of subjects: 74
Study 9032510 — intervention group
Group type: COMPARATOR
Intervention: Misled into believing breathing was not recorded
Number of subjects: 74
Study 9032510 — intervention group
Group type: COMPARATOR
Intervention: Breathing recorded for 5 min
Number of subjects: 74
Study 8286287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac (75 mg)
Number of subjects: 50
Study 8286287 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 50
Study 31433134 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoUltra: 2.5 ml of 7% MA for 30 s, followed by EndoUltra activation for 30 s
Number of subjects: 30
Study 31433134 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSafe: EndoSafe irrigation system for 1 minute using 5 ml of 7% MA
Number of subjects: 30
Study 31433134 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐vented needle: 30 gauge needle irrigation for 1 min using 5 ml of 7% MA
Number of subjects: 30
Study 28407232 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild therapeutic hypothermia (cooling to 33 ± 1 °C core temperature) initiated out of hospital and/or in hospital
Number of subjects: 1812
Study 28407232 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild therapeutic hypothermia (cooling in hospital only)
Number of subjects: 1812
Study 28407232 — intervention group
Group type: COMPARATOR
Intervention: No therapeutic hypothermia (not cooled)
Number of subjects: 1812
Study 25450818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day, n=46)
Number of subjects: 88
Study 25450818 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg/day, n=42)
Number of subjects: 88
Study 25450818 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Pioglitazone and Metformin
Number of subjects: 88
Study 23279120 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention plus usual care
Number of subjects: 82
Study 23279120 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 82
Study 21685236 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat intake
Number of subjects: 356
Study 21685236 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum TIBC
Number of subjects: 356
Study 21685236 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum UIBC
Number of subjects: 356
Study 21685236 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ferritin, iron, transferrin saturation
Number of subjects: 356
Study 21685236 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymorphisms in genes involved in iron homeostasis
Number of subjects: 356
Study 18281113 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium orotate (6000 mg for 1 month, 3000 mg for about 11 months, n=40)
Number of subjects: 79
Study 18281113 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=39)
Number of subjects: 79
Study 18281113 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium orotate
Number of subjects: 79
Study 18281113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 16948809 — intervention group
Group type: EXPERIMENTAL
Intervention: RWJ-351647 (1, 2, and 5 mg doses)
Number of subjects: 24
Study 16948809 — intervention group
Group type: EXPERIMENTAL
Intervention: RWJ-351647 (5 mg)
Number of subjects: 24
Study 16948809 — intervention group
Group type: EXPERIMENTAL
Intervention: RWJ-351647
Number of subjects: 24
Study 16948809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 15280142 — intervention group
Group type: EXPERIMENTAL
Intervention: Survanta
Number of subjects: 0
Study 15280142 — intervention group
Group type: COMPARATOR
Intervention: Alveofact
Number of subjects: 0
Study 11380515 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E therapy
Number of subjects: 26
Study 11380515 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 26
Study 11380515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 11380515 — intervention group
Group type: EXPERIMENTAL
Intervention: NG-Monomethyl-L-arginine (L-NMMA)
Number of subjects: 26
Study 11380515 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic exercise, ACh, SNP
Number of subjects: 26
Study 9421595 — intervention group
Group type: EXPERIMENTAL
Intervention: One-incision technique
Number of subjects: 30
Study 9421595 — intervention group
Group type: COMPARATOR
Intervention: Two-incision technique
Number of subjects: 30
Study 9421595 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 30
Study 8308937 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone combined with clonidine
Number of subjects: 0
Study 8308937 — intervention group
Group type: COMPARATOR
Intervention: Clonidine alone
Number of subjects: 0
Study 3471304 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 25
Study 3471304 — intervention group
Group type: COMPARATOR
Intervention: Indalpine or Citalopram
Number of subjects: 25
Study 27577039 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational and motivational drinking-reduction interventions
Number of subjects: 0
Study 27577039 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27538352 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole augmentation
Number of subjects: 0
Study 27538352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24929883 — intervention group
Group type: EXPERIMENTAL
Intervention: Halobetasol 0.05% ointment
Number of subjects: 20
Study 24929883 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 20
Study 22738918 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmoteplase
Number of subjects: 216
Study 22738918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 20634440 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of Strength suicide prevention program
Number of subjects: 453
Study 18566839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide therapy
Number of subjects: 52
Study 18566839 — intervention group
Group type: COMPARATOR
Intervention: Combination of intravenous dexamethasone and oral cyclophosphamide therapy
Number of subjects: 52
Study 16783294 — intervention group
Group type: COMPARATOR
Intervention: Vaginal suppositories containing Lactobacillus acidofilus
Number of subjects: 60
Study 16783294 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal suppositories containing Lactobacillus acidofilus + oral Lactobacillus paracasei subsp paracasei F19
Number of subjects: 60
Study 14557449 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose soy isoflavones (1.0 g soy extracts, approximately 80 mg isoflavones)
Number of subjects: 203
Study 14557449 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-dose soy isoflavones (0.5 g starch, 0.5 g soy extracts, approximately 40 mg isoflavones)
Number of subjects: 203
Study 14557449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 g starch)
Number of subjects: 203
Study 11099619 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological functioning (IQ < 70)
Number of subjects: 722
Study 11099619 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological functioning (IQ = 70-89)
Number of subjects: 722
Study 11099619 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological functioning (IQ > 90)
Number of subjects: 722
Study 11099619 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor dysfunction (reduced muscle mass)
Number of subjects: 722
Study 11099619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical atrophy
Number of subjects: 722
Study 11099619 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 48 neuropsychological functioning
Number of subjects: 722
Study 8871338 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnotic relaxation
Number of subjects: 30
Study 8871338 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-hypnotic relaxation)
Number of subjects: 30
Study 1497048 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced respiration
Number of subjects: 33
Study 1497048 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle relaxation
Number of subjects: 33
Study 1497048 — intervention group
Group type: COMPARATOR
Intervention: Alpha-wave electroencephalographic biofeedback
Number of subjects: 33
Study 6338794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide
Number of subjects: 20
Study 6338794 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection (placebo)
Number of subjects: 20
Study 6338794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide (after placebo failure)
Number of subjects: 20
Study 6338794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional steroid therapy (combined results)
Number of subjects: 20
Study 30767962 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression in patients with cancer
Number of subjects: 716
Study 30767962 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression in family caregivers (FCs)
Number of subjects: 716
Study 29153532 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind pushing technique for PICC placement through brachial vein access
Number of subjects: 1043
Study 29153532 — intervention group
Group type: COMPARATOR
Intervention: Brachial vein access
Number of subjects: 1043
Study 29153532 — intervention group
Group type: COMPARATOR
Intervention: Nonbrachial vein access
Number of subjects: 1043
Study 27009620 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blocker (n=833)
Number of subjects: 2484
Study 27009620 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor (n=821)
Number of subjects: 2484
Study 27009620 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockade (n=830)
Number of subjects: 2484
Study 27009620 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening variability independent of the mean (before treatment)
Number of subjects: 2484
Study 27009620 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning measurement of BPV
Number of subjects: 2484
Study 27009620 — intervention group
Group type: EXPERIMENTAL
Intervention: Home BPV captured after monotherapy
Number of subjects: 2484
Study 25401780 — intervention group
Group type: EXPERIMENTAL
Intervention: Optional mucosal sampling
Number of subjects: 211
Study 25401780 — intervention group
Group type: COMPARATOR
Intervention: Volunteers from Soweto
Number of subjects: 211
Study 25401780 — intervention group
Group type: COMPARATOR
Intervention: Volunteers from Klerksdorp
Number of subjects: 211
Study 25401780 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteers over 25 years of age
Number of subjects: 211
Study 23045543 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation intervention
Number of subjects: 319
Study 23045543 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 319
Study 20142543 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-receptor blocker (losartan potassium) or angiotensin-converting enzyme inhibitor (enalapril maleate)
Number of subjects: 147
Study 20142543 — intervention group
Group type: COMPARATOR
Intervention: Daytime ambulatory systolic BP
Number of subjects: 147
Study 20142543 — intervention group
Group type: COMPARATOR
Intervention: Daytime ambulatory diastolic BP
Number of subjects: 147
Study 20142543 — intervention group
Group type: COMPARATOR
Intervention: Nighttime ambulatory systolic BP
Number of subjects: 147
Study 20142543 — intervention group
Group type: COMPARATOR
Intervention: 24-hour ambulatory systolic BP
Number of subjects: 147
Study 17324145 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily for 12 weeks, followed by placebo for 2 weeks and then metoprolol succinate 95 mg once daily for 12 weeks
Number of subjects: 0
Study 17324145 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol succinate 95 mg for 12 weeks, placebo for 2 weeks and then nebivolol 5 mg for 12 weeks
Number of subjects: 0
Study 17120843 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary learning with landmark cognitive style
Number of subjects: 0
Study 17120843 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary learning with landmark cognitive style
Number of subjects: 0
Study 17120843 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary learning with route cognitive style
Number of subjects: 0
Study 17120843 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary learning with survey cognitive style
Number of subjects: 0
Study 17120843 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary learning with route cognitive style
Number of subjects: 0
Study 17120843 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary learning with survey cognitive style
Number of subjects: 0
Study 12066489 — intervention group
Group type: EXPERIMENTAL
Intervention: Southern Implants
Number of subjects: 72
Study 12066489 — intervention group
Group type: EXPERIMENTAL
Intervention: Steri-Oss
Number of subjects: 72
Study 12066489 — intervention group
Group type: EXPERIMENTAL
Intervention: ITI
Number of subjects: 72
Study 12066489 — intervention group
Group type: COMPARATOR
Intervention: All implant systems
Number of subjects: 72
Study 12066489 — intervention group
Group type: EXPERIMENTAL
Intervention: ITI and Steri-Oss
Number of subjects: 72
Study 10703876 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss with exercise training
Number of subjects: 0
Study 10703876 — intervention group
Group type: COMPARATOR
Intervention: Weight loss without exercise training (diet-only group)
Number of subjects: 0
Study 10703876 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (both groups)
Number of subjects: 0
Study 8724090 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar disc surgery for patients with disc herniation only
Number of subjects: 164
Study 8724090 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar disc surgery for patients with diagnoses other than disc herniation
Number of subjects: 164
Study 8724090 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictor score for patients with disc herniation only
Number of subjects: 164
Study 8724090 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain management approach for high-risk patients
Number of subjects: 164
Study 1718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (encainide/flecainide)
Number of subjects: 1498
Study 1718158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1498
Study 1718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated idioventricular rhythm < 100 beats/min
Number of subjects: 1498
Study 6224684 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg twice daily
Number of subjects: 40
Study 6224684 — intervention group
Group type: COMPARATOR
Intervention: Cotrimoxazole 160/800 mg twice daily
Number of subjects: 40
Study 31699046 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedding Package (intervention to increase uptake of structured self-management education)
Number of subjects: 66
Study 31699046 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedding Package
Number of subjects: 66
Study 31699046 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 66
Study 29180206 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine wound infiltration
Number of subjects: 40
Study 29180206 — intervention group
Group type: COMPARATOR
Intervention: Placebo wound infiltration
Number of subjects: 40
Study 25101527 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback (FB) using the OQ‐Analyst and Outcome Questionnaire‐45.2
Number of subjects: 259
Study 25101527 — intervention group
Group type: COMPARATOR
Intervention: No Feedback (NFB)
Number of subjects: 259
Study 24832559 — intervention group
Group type: EXPERIMENTAL
Intervention: Film-coated ethionamide tablets (250 mg)
Number of subjects: 40
Study 24832559 — intervention group
Group type: COMPARATOR
Intervention: Sugar-coated ethionamide tablets (250 mg)
Number of subjects: 40
Study 23190833 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte- and platelet-rich fibrin
Number of subjects: 68
Study 23190833 — intervention group
Group type: COMPARATOR
Intervention: Vaselitulle (petroleum jelly mesh)
Number of subjects: 68
Study 19052457 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Behavior Game intervention (n = 263)
Number of subjects: 477
Study 19052457 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 214)
Number of subjects: 477
Study 17894303 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based ribavirin (RBV) 800-1400 mg/day
Number of subjects: 5027
Study 17894303 — intervention group
Group type: COMPARATOR
Intervention: Flat-dose ribavirin (RBV) 800 mg/day
Number of subjects: 5027
Study 17894303 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based RBV in genotype 1 patients
Number of subjects: 5027
Study 17894303 — intervention group
Group type: COMPARATOR
Intervention: Flat-dose RBV in genotype 1 patients
Number of subjects: 5027
Study 17894303 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based RBV in genotype 1 patients with high baseline viral load
Number of subjects: 5027
Study 17894303 — intervention group
Group type: COMPARATOR
Intervention: Flat-dose RBV in genotype 1 patients with high baseline viral load
Number of subjects: 5027
Study 17894303 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based RBV in genotype 2/3 patients
Number of subjects: 5027
Study 17894303 — intervention group
Group type: COMPARATOR
Intervention: Flat-dose RBV in genotype 2/3 patients
Number of subjects: 5027
Study 14766435 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 0
Study 14766435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11385386 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (36 degrees C)
Number of subjects: 24
Study 11385386 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic cardiopulmonary bypass (30 degrees C)
Number of subjects: 24
Study 9227164 — intervention group
Group type: EXPERIMENTAL
Intervention: etidronate + sodium fluoride (NaF) 25 mg twice daily
Number of subjects: 47
Study 9227164 — intervention group
Group type: COMPARATOR
Intervention: etidronate + placebo
Number of subjects: 47
Study 7958497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 7958497 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ANG II infusion
Number of subjects: 11
Study 7958497 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ANG II infusion
Number of subjects: 11
Study 3516085 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 41
Study 3516085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 30977767 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum sodium levels (≥141 mmol/L)
Number of subjects: 8813
Study 30977767 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline serum sodium levels
Number of subjects: 8813
Study 29033294 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 4,000 mg/day
Number of subjects: 547
Study 29033294 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 150 mg/day
Number of subjects: 547
Study 29033294 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 4,000 mg/day + Diclofenac 150 mg/day
Number of subjects: 547
Study 27737649 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release melatonin (2 mg)
Number of subjects: 48
Study 27737649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 27737649 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine tapering
Number of subjects: 48